Follow the 디앤디파마텍 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 디앤디파마텍 has published 36 insider filings. Market capitalisation: €3,294.1bn. The latest transaction was disclosed on 11 June 2026 (Other). Among the most active insiders: 신재희. All data is accessible without an account.
36
Insider Decl.
0
Thresholds
·
6 ops.
Buy Volume
·
7 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,387 of 25,571 companies
42.9
score / 100
Value
32
Quality
54
FCF yld-0.6%
Earn yld-0.6%
EV/EBITDA·
ROE-35%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
디앤디파마텍 is a company listed on the XKRX market, specializing in the healthcare and pharmaceutical sector. It focuses on developing innovative solutions for disease treatment.